|
221 |
Chinese herbal medicine TangBi Formula treatment of patients with type 2 diabetic distal symmetric polyneuropathy disease: study protocol for a randomized controlled trial
Enthalten in Trials Bd. 18, 29.12.2017, Nr. 1, date:12.2017: 1-10
|
|
|
|
222 |
Choice of futility boundaries for group sequential designs with two endpoints
Enthalten in BMC medical research methodology Bd. 17, 8.8.2017, Nr. 1, date:12.2017: 1-10
|
|
|
|
223 |
Cidofovir
Enthalten in Reactions weekly Bd. 1688, 10.2.2018, Nr. 1, date:2.2018: 57
|
|
|
|
224 |
Cidofovir/Brincidofovir
Enthalten in Reactions weekly Bd. 1688, 10.2.2018, Nr. 1, date:2.2018: 58
|
|
|
|
225 |
Cinacalcet versus Placebo for secondary hyperparathyroidism in chronic kidney disease patients: a meta-analysis of randomized controlled trials and trial sequential analysis
Enthalten in Scientific reports Bd. 8, 15.2.2018, Nr. 1, date:12.2018: 1-20
|
|
|
|
226 |
Cisplatin-Therapie war eine Zufallsentdeckung
Enthalten in MMW - Fortschritte der Medizin Bd. 159, 17.7.2017, Nr. 13, date:7.2017: 19
|
|
|
|
227 |
Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/Ginkgoselect®Plus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx]
Enthalten in BMC complementary and alternative medicine Bd. 18, 22.1.2018, Nr. 1, date:12.2018: 1-12
|
|
|
|
228 |
Clinical drug trials in general practice: how well are external validity issues reported?
Enthalten in BMC family practice Bd. 18, 29.12.2017, Nr. 1, date:12.2017: 1-11
|
|
|
|
229 |
Clinical features of Parkinson’s disease patients are associated with therapeutic misconception and willingness to participate in clinical trials
Enthalten in Trials Bd. 18, 29.9.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
230 |
Clinical interventions, implementation interventions, and the potential greyness in between -a discussion paper
Enthalten in BMC health services research Bd. 17, 7.1.2017, Nr. 1, date:12.2017: 1-10
|
|
Administration
